Home › Companies › Easy BIO

Easy BIO

이지바이오 · 353810 · KOSDAQ
Filings, last 12 months
23
Supply contracts
0
Insider reports
0
Share & bond issues
0

At a glance

Easy BIO filed 23 disclosures in the last 12 months, including 3 5% holder. The most recent key filing was on Oct 19: A major holder's stake rose from 6.75% to 7.87%.

Revenue for 2025 was ₩477B, up 24.1% on 2024. Operating margin was 9.4% against 8.4% a year earlier. Debt was 188% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩279B and operating profit of ₩28.3B.

The 2025 annual report lists 143 employees with an average tenure of 3.9 years and average pay of ₩62.8M, #850 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩204M each on average. It paid ₩250 per common share in cash dividends, against ₩200 a year earlier (+25%). (주)이지홀딩스 and related parties held 51.53% at year end.

Of 1 recent 5%+ holder report, 1 raised and 0 cut a stake; the largest stake reported was 7.87% on Oct 19.

From the 2025 annual report

Employees
143
Average pay
₩62.8M
Average tenure
3.9 yrs
Avg. director pay
₩204M

Staff: 143 (103 men, 40 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩9B. Directors and auditors: 7, paid ₩1.4B in total.

Dividends (common shares)

Fiscal year202520242023
Cash dividend per share₩250₩200₩100
Payout ratio29.8%33.8%22%
Yield (as filed)3.31%4.55%2.82%
Total cash dividends₩8.3B₩6.6B₩3.4B

Largest shareholder

(주)이지홀딩스 holds 50.16%; with 3 related parties the group holds 51.53% of common shares at year end (from 49.83% at the start of the year).

Auditor: 이촌회계법인 · opinion: Unqualified. The report includes an emphasis of matter.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

2023
Revenue ₩165B
Op. profit ₩20.6B
Debt/equity 160%
2024
Revenue ₩384B
Op. profit ₩32.4B
Debt/equity 305%
2025
Revenue ₩477B
Op. profit ₩45B
Debt/equity 188%
2026 H1
Revenue ₩279B
Op. profit ₩28.3B
Debt/equity 192%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

5%+ holder reports

10/19Stake 7.87%+1.12pp

Key filings

Other filings

Links open the original filing on DART, in Korean.